Исследование сывороточных аутоантител к некоторым гепарин-связывающим белкам головного мозга в норме и при патологии
Диссертация
Актуальность проблемы. Уже много лет проблемы аутоиммунитета привлекают к себе нарастающее внимание. Это связано, с одной стороны, с обнаружением новых проявлений и биологических ролей этой функции иммунной системы, а с другой — доказательств вовлеченности нарушений аутоиммунитета в различные патологические процессы. Получено множество экспериментальных данных, подтверждающих теорию сетевой… Читать ещё >
Содержание
- 1. Обзор литературы
- 1. 1. Роль факторов роста в регуляции физиологических процессов
- 1. 2. Важнейшие представители факторов роста
- 1. 1. 1. Фактор роста фибробластов
- 1. 1. 2. Плейотрофин
- 1. 1. 3. Амфотерин
- 1. 1. 4. Семейство сосудисто-эндотелиальных факторов роста 1.1.4.1 Плацентарный фактор роста
- 1. 1. 5. Семейство нейротрофических ростовых факторов
- 1. 1. 6. Инсулиноподобные факторы роста
- 1. 1. 7. Эпидермальный фактор роста
- 1. 1. 8. Ангиогенин
- 1. 3. Роль аутоиммунитета в норме и патологии
- 2. Материалы и методы исследования
- 2. 1. Экспериментальный материал
- 2. 2. Применяемые реактивы и буферные растворы
- 2. 3. Получение ОБ АР
- 2. 4. Получение плейотрофина и амфотерина
- 2. 5. Получение белка НВР
- 2. 6. Определение АТ к изучаемым белковым антигенам в биологических жидкостях методом твердофазного ИФА
- 2. 7. Стандартизация систем иммуноферментного анализа
- 2. 8. Получение иммуноаффинного сорбента
- 2. 9. ДСН-электрофорез в ПААГ
- 2. 10. Иммуноблоттинг
- 2. 11. Определение количества белка
- 3. Результаты исследования
- 3. 1. Исследование аутоиммунной реактивности к гепарин-связывающим ростовым факторам амфотерину и плейотрофину в здоровом организме и при некоторых патологических состояниях
- 3. 2. Получение белка НВР-60. Исследование сывороточной иммунореактивности к НВР-60 в норме и при различной патологии
Список литературы
- Абрамов В.В. Взаимодействие нервной и иммунной систем. Новосибирск, Наука, 1988
- Агеенко А.И. Лицо рака. М., Медицина, 1994
- Бурлев В.А., Зайдиева З. С., Тютюник В. Л., Кравченко Н. Ф., Павлович C.B., Коновалова E.H. Роль ростовых факторов в плацентарной недостаточности. Проблемы репродукции, 2000,6:36−45
- Бурлев В.А., Павлович C.B. Ангиогенез и ангиогенные факторы роста в регуляции репродуктивной системы у женщин. Проблемы репродукции, 1998, 6:23−34
- Донцов В.И. Лимфоцитарная регуляция клеточной пролифераци: альтернатива теории противоопухолевого контроля. Иммунология, 1989, 8:94−6
- Иващенко Ю.Д., Быкорез А. И. Полипептидные факторы роста и канцерогенез. Киев, Наукова Думка, 1990
- Клюшник Т.П. Аутоантитела к фактору роста нервов принервно-психических заболеваниях и нарушениях развития нервной системы. Докт. дисс., М., 1997
- Крыжановский Г. Н., Луценко В. К. Значение нейротрофических факторов для патологии нервной системы. Успехи современной биологии, 1995 1:31−48
- Кэтти Д. и Райкундалия Ч. Иммунодиффузия в геле, иммуноэлектрофорез и методы иммунохимического окрашивания. // В кн.: Антитела. Методы. Д. Кэтти (ред.). М., «Мир», 1991, Т. 1, 230−237
- Морозов С.Г. Антитела к белкам нервной ткани при нервных и психических заболеваниях (иммунохимическое и клинико-иммунологическое исследование). Докт. дисс., М., 1997
- Пальцев М.А., Иванов A.A. Межклеточные взаимодействия. М., Медицина, 1995
- Полетаев А.Б., Вабищевич Н. К. Состояние системы естественного иммунитета у женщин фертильного возраста и риск нарушения развития эмбриона и плода. Вестн. Рос. Ассоц. Акуш. Гинекол., 1997,3:37−41.
- Полетаев А.Б., Морозов С.Г. Инструкция по применению набора реагентов для полуколичественного определения регуляторных аутоантител в сыворотке крови женщин детородного возраста «ЭЛИ-П-ТЕСТ» Москва, Медико-Экологический Фонд «Чернобыль-тест», 1999
- Полетаев А.Б., Селифанова О. П. Физико-химическая характеристика видонеспецифических белковых антигенов мозга, являющихся мишенями аутоантител при некоторых нервно-психических заболеваниях человека. Нейрохимия, 1987 6(4)-572−80
- Теппермен Дж., Теппермен X. Физиология обмена веществ и эндокринной системы. М., Мир, 1989
- Тигранян Р.А., Калита Н. Ф., Роганов А. С. Методическое руководство по проведению контроля качества наборов реагентов для иммуноферментного анализа. ГНИИ стандартизации и контроля лекарственных средств МЗ РФ, Москва, 1994
- Achen M.G., Gad J.M., Stacker S.A., Wilks A.F. Placenta growth factor and vascular endothelial growth factor are co-expressed during early embryonic development. Growth Factors, 1997, 15:69−80
- Achen M.G., Stacker S.A. The vascular endothelial growth factor family: proteins, which guide the development of the vasculature. Int. J. Exp. Pathol., 1998, 79(5):255−65
- Albeck D., Rose G.M., Veng L., Bartus R., Granholm A.C. Electrophysiological effects of OX-26-NGF on medial septal neurons. Soc. Neurosci. Abstr., 1996, 22(pt 1):752
- Armelin H.A., Armelin M.C.S., Kelly Т., Stewart P., Leder P., Cochran B.H. and Stiles C.D. Functional role of с myc in mitogenic response to platelet derived growth factors precedes activation of с myc. Nature, 1984,310:655−60
- Badet J, Soncin F., Guitton J.-D., Lamare O., Cartwright Т., Barritault D. Specific binding of angiogenin to calf pulmonary artery endothelial cells. Proc. Natl. Acad. Sci. USA. 1989, 86:8427−33
- Badet J. Angiogenin, a potent mediator of angiogenesis. J. Path. Biol. 1999, 47(4): 345−51
- Baird A., Esch F., Gospodarowicz D. and Guillemin R. Retina-derived endothelial cell growth factors: partial molecular characterization identity with acidic and basic fibroblast growth factor. Biochemistry, 1985, 24:7855−59
- Baird A., Mormede P. and Bohlen P. Immunoreactive fibroblast growth factor in cells of peritoneal exudates suggest its identity with macrophage derived growth factor. BBRC, 1985, 126:358−64
- Barde Y.A. Trophic factors and neuronal survival. Neuron, 1989, 2(6): 1525−34
- Bashkin P., Doctrow S., Klagsbrun M., Svahn С. M., Folkman J. and Vlodavsky I. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry, 1989, 28:1737−43
- Bicknell R., Vallee B.L. Angiogenin stimulates endothelial cell prostacyclin secretion by activation of phospholipase A. Proc. Natl. Acad. Sci. USA 1989, 86:1573−77
- Bikfalvi A., Klein S., Pintucci G., Rifkin D.B. The roles of proteases in angiogenesis // Tumor angiogenesis. Oxford University Press, 1997, 115−24
- Casali P., Notkins A.L. CD5+ B-lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunology Today, 1989, 10(2):364−68
- Carolyn A. Bondy and Wei-Hua Lee. Patterns of Insulin-Like Growth Factor and IGF Receptor gene expression in the Brain. Ann. NY Acad. Sci., 1993, 692:33−43
- Chamoux M., Dehouck M.P., Fruchart J.C., Spik G., Montreuil J., Cecchelli R. Characterization of angiogenin receptors on bovine brain capillary endothelial cells. BBRC, 1991, 176:833−39
- Choudhuri R., Zhang H.T., Donnini S., Ziche M., Bicknell R. An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res., 1997 May 1, 57(9): 1814−9
- Clementi F., Tronconi B.C., Fumagalli G., Pedretti D., Brigonzi S. The use of antibodies in neuroscience. Effects of antibodies against acetylcholine receptor and acetylcholinesterase. Pharmacol Res Commun., 1980 Jun, 12(6):611−7
- Cohen I.R., Young D.B. Autoimmunity, microbial immunity and the immunological homunculus. Immunology Today, 1991, 12(3): 10 510
- Cohen S. Epidermal growth factor. In Vitro Cell Dev Biol., 1987 Apr, 23(4):239−46
- Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J. Biol. Chem., 1962, 237:1555−62
- Connolly D.T., Heuvelmann D.M., Nelson R., Olander J.V., Eppley B.L., Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest., 1989 Nov, 84(5): 1470−8
- D’Amerval C. A simplification of Heukeshoven and Dernick silver staining of proteins. Electrophoresis, 1987, 8:158−9
- Daston M.M., Ratner N. Amphoterin (p30, HMG-1) and RIP are early markers of oligodendrocytes in the developing rat spinal cord. J. Neurocytol 1994 May- 23(5):323−32
- Desai J, Holt-Shore V., Tony R.J., Caudle M.R., Tony D.S. Signal transduction and biological function of placenta growth factor in primary human trophoblast. Biol. Reprod., 1999,60:887−92
- DiNola F. Le immunoglobuline umane. Minerva Med., 1988, 79(6):481−94
- Downward J., Parker P., Waterfield M. Autophosphorylation sites on the EGF receptor. Nature, 1985, 311:483−85
- Dreyfus C.F. Effects of nerve growth factor on cholinergic brain neurons. Trends Pharmacol Sci., 1989 Apr, 10(4):145−9
- Dreyfus C.F., Bernd P., Martinez H.J., Rubin S.J., Black I.B. GABAergic and cholinergic neurons exhibit high-affinity nerve growth factor binding in rat basal forebrain. Exp Neurol., 1989 May, 104(2): 181−5
- Dvorak H.F., Nagy J.A., Feng D., Dvorak A.M. Vascular Permeability FactorWascular endotelial Growth Factor and the significance of microvascular Hyperpermeability. In: Angiogenesis // Springer-Verlag, 1999.-Vol.237. 98−130
- Ellis V., Dano K. Plasminogen activation by receptor-bound urokinase. Semin. Thromb. Haemost., 1991 Jul, 17(3): 194−200
- Erkki Raulo, Ilkka Julkunen, Jussi Merenmies, Riitta Pihlaskari and Heikki Rauvala. Secretion and Biological Activities of Heparin-binding Growth-associated Molecule. J. Biol. Chem. 1992 June 5, 267(16): 11 408−16
- Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev., 1997, 18(l):4−25
- Finney K.J., Ince P., Appleton D.R. A trophic effect of epidermal growth factor (EGF) on rat colonic mucosa in organ culture. Cell and Tissue Kinet., 1987, 20:43:56
- Florkiewicz R.Z., Baird A., Gonzalez A.M. Multiple forms of bFGF: differential nuclear and cell surface localization. Growth Factors, 1991, 4(4):265−75
- Gao G. and Goldfarb M. Heparin can activate a receptor tyrosine kinase. EMBO J., 1995, 14:2183−90.
- Gieffers C., Engelhardt W., Brenzel G., Matsuishi T., Frey J. Receptor binding of osteoblast-specific factor 1 (OSF-1/HB-GAM) to human osteosarcoma cells promotes cell attachment. Eur. J. Cell Biol., 1993, 62(2):352−61
- Gospodarowicz D. and Bialecki H. The effects of the epidermal and fibroblast growth factors on the replicative lifespan of cultured bovine granulosa cells. Endocrinology, 1978 Sep, 103(3):854−65
- Gospodarowicz D. and Neufeld G. Fibroblast growth factor: molecular and biological properties//In: Mesenchymal-Epithelial Interactions in neural Development. Heidelberg, Springer-Verlag, 1987
- Gospodarowicz D. Fibroblast growth factor: structural and biological properties. Int. J. Rad. Appl. Instrum. Biol., 1987, 14(4):421−34
- Gospodarowicz D., Moran J.S. Mitogenic Effect of fibroblast growth factor on early passage cultures of human and murine fibroblasts. J. Cell Biol., 1975, 66(2):451−7
- Guimond S., Maccarana M., 01 win B. B., Lindahl U. and Rapraeger A. C. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J. Biol. Chem., 1993,268:23 906−14
- Guroff G. Nerve Growth Factor as a Neurotrophic Agent. Annals of the NY Acad, of Sci, 1993, 692:51−9
- Hatva E., Kaipainen A., Mentula P., Jaaskelainen J., Paetau A., Alitalo K. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am. J. Pathol., 1995, 146(2):368−78
- Hauser S., Weich H.A. A heparin-binding form of placenta growth factor (P1GF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors, 1993, 9(4):259−68
- Hefti F., Weiner W.J. Nerve growth factor and Alzheimer’s disease. Ann. Neurol., 1986, 20(3):275−81
- Houck K.A., Leung D.W., Rowland A.M., Winer J., Ferrara N. Dual Regulation of Vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem., 1992 Dec 25, 267(36):26 031−7
- Huston J.S., Bignami A. Structural properties of the glial fibrillary acidic protein, Evidence for intermolecular disulfide bonds. Biochim Biophys Acta, 1977 Jul 22,493(1):93−103.
- Ilkonen E., Parton R.G., Hunziker W., Simons K., Dotti C.G. Transcytosis of the polyraericimmunoglobulin receptors in cultured hippocampal neurons. Curr. Biol., 1993, 5(3):635−44
- Imai S., Kaksonen M., Raulo E., fages C., Meng X., Rauvala H. Osteoblast recruitment and bone formation enhanced by cell matrix-associated heparin-binding growth-associated molecule (HB-GAM). J. Cell Biol., 1998 Nov 16,143(4): 1113−28
- Jerne N.K. Immune network. Ann. Inst. Pasteur Immunol., 1974, 125C:435−41
- Jimi S.-I., Ito K.-J., Konho K., Ono M., Kuwano M., Itagaki Y., Ishikawa H. Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells. BBRC, 1995,211:476−83
- Khaliq A., Li X.F., Shams M., Sisi P., Acevedo C.A., Whittle M.J., Weic H., Ahmed A. Localization of placenta growth factor (P1GF) in human term placenta. Growth Factors, 1996,13:243:50
- Kinnunen A., Niemi M., Kinnunen T., Kaksonen M., Nolo R., Rauvala H. Heparan sulphate and HB-GAM (heparin-binding growth-associated molecule) in the development of the thalamocortical pathway of rat brain. Eur. J. Neurosci., 1999 Feb, 11(2):491−502
- Kinnunen T., Kaksonen M., Saarinen J., Peng H.B., Rauvala H. Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth. J. Biol. Chem., 1998 Apr 24, 273(17): 10 702−8
- Klagsbrun M., Moses M.A. Molecular angiogenesis. Chem. Biol., 1999 Aug, 6(8):217−24
- Landor M. Maternal-fetal transfer of immunoglobulins. Ann. Allergy, Asthma & Immunol., 1995, 74(4):279−83
- Lauri S.E., Taira T., Kaila K., Rauvala H. Activity-induced enchancement of HB-GAM expression in rat hippocampal slices. Neuroreport, 1996 Jul 8, 7(10):1670−4
- LeRoith D., Werner H., Faria T.N., Kato H., Adamo M. and Roberts C.T. (jr). Insulin-like Growth Factor Receptors. Implication for Nervous System Function. Annals of the NY Acad. Sci., 1993, 692:22−32
- Levy A.P., Levy N.S., Goldberg M.A. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. J. Biol. Chem., 1996 Oct 11, 271(41):25 492−7
- Li D., Bell J., Brown A., Berry C.L. the observation of angiogenin and basic fibroblast growth factor gene expression in human colonic adenocarcinomas, gastric adenocarcinomas and hepatocellular carcinomas. J. Pathol., 1994,172:171−75
- Maglione D., Guerriero V., Viglietto G., Bovi P., Persico M.G. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA, 1991 Oct 15, 88(20):9267−71
- Margini R.A. and Borel I.M. paradoxical behavior of asymmetric IgG antibodies. Immunol. Rev., 1998, 163(l):77−87
- McMorris F.A., Mozell R.L., Carson M.J., Shinar Y., Meyer R.D. and Marchetti N. Regulation of Oligodendrocyte Development and Central Nervous System Myelination by Insulin-like Growth Factors. Annals of the NY Acad. Sci, 1993 692:321−33
- Meccoci P., Parnetti L., Romano G. Serum anti-GFAP and SI00 autoantibodies in brain aging, Alzheimer’s disease and vascular dementia. J. of Neuroimmunology, 1995, 57:165−70
- Moore F., Riordan J.F. Angiogenin activates phospholipase C and elicits a rapid incorporation of fatty acid into cholesterol esters in vascular smooth muscle cells. Biochemistry, 1990, 29:228−33
- Muller R., Wagner E.F. Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes. Nature, 1984 Oct 4−10, 311(5985):438−42
- Nathalia Locopo, Massimo Fanelli and Giampietro Gasparini. Clinical significance of angiogenic factors in breast cancer. Breast Cancer research and Treatment, 1998, 52:159−73
- Nishimoto I., Murayama Y., Katada T., Ui M. and Ogata E. Possible direct linkage of insulin-like growth factor-II receptor with guanine nucleotide-binding proteins. J. Biol. Chem., 1989,254:14 029−38
- Ohyama Y., Miyamoto K., Minamino N., Matsuo H. Isolation and identification of midkine and pleiotrophin in bovine follicular fluid. Mol. Cell. Endocrinol., 1994 Nov. 105(2):203−8
- Papadimitriou E., Heroult M., Courty J., Polykratis A., Katsoris P. Endothelial cell proliferation induced by HARP: implication of N or C terminal peptides. BBRC. 2000 Jul 21, 274(l):242−8
- Parkkinen J, Rauvala H. Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enchancement of t-PA-catalysed plasminogen activation by amphoterin. J. Biol Chem 1991 Sep 5−266(25):16 730−5
- Peng H.B., Ali A.A., Dai Z., Daggett D.F., Raulo E., Rauvala H. The role of heparin-binding growth-associated molecule (HB-GAM) in the postsynaptic induction in cultured muscle cells. J. Neurosci., 1995 Apr, 15(4):3027−38
- Pepper M.S., Mandriota S.J., Vassalli J.D., Orci L., Montesano R. Angiogenesis-regulating cytokines: activities and interactions. Cur. Top. Microbiol. Immunol., 1996, 213:31−67
- Poletaev A.B., Selifanova O.P. transfer of elevated anti-SlOO autoimmunity from mother to offspring in rats. Life Sci., 1994, 54(18): 1377−81
- Radosevic-Stasic B. interference between immune functions and normal growth. Period. Biologorum, 1980, 82:83−87
- Rapraeger A. C., Krufka A. and Olwin B. B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science, 1991, 252:1705−08
- Raulo E., Chernousov M.A., Carey D.J., Nolo R, Rauvala H. Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3). J. Biol. Chem., 1994 Apr 29, 269(17): 12 999−3004
- Rauvala H, Huttunen HJ, Fages C, Kaksonen M, Kinnunen T, Imai S, Raulo E. Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility. Matrix Biol 2000 Sep- 19 (5):377−87
- Rauvala H. An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factors. The EMBO J., 1989, 8(10):2933−41
- Rauvala H. and Pihlaskari R. Isolation and some characteristics of an adhesive factor of brain that enchances neurite outgrowth in central neurons. J. Biol. Chem, 1987,262:16 625−35
- Rodriguez-Tebar A., Dechant G., Barde Y.A. Binding of brain-derived neurotrophic factor to the nerve growth factor receptor. Neuron, 1990 Apr, 4(4):487−92.
- Rouhiainen A, Imai S, Rauvala H, Parkkinen J. Occurence of amphoterin (HMG-1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb Haemost 2000 Dec-84(6): 1087−94
- Rudland P. S., Seifert W., Gospodarowicz D. Growth control in cultured mouse fibroblasts: induction of the pleiotypic and mitogenic responses by a purified growth factor. Proc. Natl. Acad. Sci. USA, 1974 Jul, 71(7):2600−4
- Saksela O., Moscatelli D., Sommer A. and Rifkin, D.B. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol., 1988,107:743−51
- Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta, 2000 Dec 20,1498(2−3):99-l 11
- Shapiro R., Weremowicz S., Riordan J.F., Vallee B.L. Ribonucleolytic activity of angiogenin: essential histidine, lysine and arginine residues. Proc. Natl. Acad. Sci. USA, 1987, 84:8783−87
- Shimoyama S., Gansauge F., Gansauge S., Negri g., Oohara T., Berger
- H.G. Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res., 1996, 56:2703−06
- Shults C.W. Future perfect? Presymptomatic diagnosis, neural transplantation and trophic factors. Neurol. Clin., 1992, 10(2):567−93
- Soncin F. Angiogenin supports endothelial and fibroblast cell adhesion. Proc. Natl. Acad. Sci. USA, 1992, 89:2232−36
- Sparatore B, Patrone M., Passalacqua M, Pedrazzi M, Gaggero D, Pontremoli S, Melloni E. Extracellular processing of amphoterin generates a peptide active on erythroleukaemia cell differentiation. Biochem J. 2001 Jul 15−357(Pt 2):569−74
- Spivak-Krolzman T., Lemmon M. A., Dikic I., Ladbury J. E., Pinchasi D., Huang J., Jaye M., Crumley G., Schlessinger J. and Lax
- Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell, 1994, 79:1015−24
- Strydom D.J., Fett J.W., Lobb R.R., Alderman E.M., Bethune J.L. Riordan J.F., Vallee B.L. Amino acid sequence of human tumor derived angiogenin. Biochemistry, 1985, 24:5486−94
- Szabat E., Rauvala H. Role of HB-GAM (heparin-binding growth-associated molecule) in proliferation arrest in cells of the developing rat limb and its expression in the differentiating neuromuscular system. Dev. Biol., 1996 Aug 25,178(l):77−89
- Takeda A., Onodera H., Sugimoto A., Itoyama Y., Rauvala H., Shibahara S. Induction of heparin-binding growth-associated moleculeexpression in reactive astrocytes following hippocampal neuron injury. Neuriscience, 1995, 68(l):57−64
- Takeuchi S. Is production of blocking antibodies in successful human pregnancy an epiphenomenona? Amer. J. Reprod. Immunol., 1990, 24(4): 108−19
- Tanaka Y., Takeda M., Kato Y. A high level of anti-GFAP autoantibody in the serum of patients with Alzheimer’s disease. Biomed. Res., 1988, 9(3):209−16
- Tessler S., Rockwell P., Hicklin D., Cohen T., Lemichka I.R., Neufeld G. Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors. J. Biol. Chem., 1994 Apr 29, 269(17): 1 245 661
- Thoenen H. The changing scene of neurotrophic factors. Trends Neurosci., 1991, 14(5): 165−70
- Torry D.S., Wang H.S., Wang T.H., Caudle M.R., Torry RJ. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am. J. Obstet. Gynecol., 1998 Dec, 179(6 Pt 1): 1539−44
- Tsutsui J., Uehara K., Kadomatsu K., Matsubara S., Muramatsu T. A new family of heparin-binding factors: strong conservation of midkine (MK) sequences between the human and the mouse. BBRC, 1991 Apr 30, 176(2):792−7
- Vassalli J.D., Sappino A.P., Belin D. The plasminogen activator/plasmin system. J. Clin. Invest., 1991 Oct, 88(4): 1067−72
- Wang B.S., Lumanglas A.L., Szewczyk E., Loullis C.S. A proposed mechanism of action of a growth hormone-specific monoclonal antibody in the enhancement of hormonal, activity. Mol. Immunol., 1992, 29(3):313−7
- Yeh H.J., He Y.Y., Hsu C.Y., Deuel T.F. Upregulation of pleiotrophin gene expression in developing microvasculature, macrophages, and astrocytes after acute ischemic brain injury. J. Neurosci., 1998 May 15, 18(10):3699−707
- Zhang N., Deuel T.F. Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin-binding growth and differentiation factors. Curr. Opin. Hematol., 1999 Jan, 6(l):44−50
- Ziche M., Maglione D., Ribatti D., Morbidelli L., Lago C.T., Battisti M., Persico M.G. Placenta growth factor is chemotactic, mitogenic and angiogenic. Lab. Invest., 1997,76:517−31